BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18254725)

  • 1. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
    Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
    Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase.
    Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y
    Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging docking and fusion of insulin granules induced by antidiabetes agents: sulfonylurea and glinide drugs preferentially mediate the fusion of newcomer, but not previously docked, insulin granules.
    Nagamatsu S; Ohara-Imaizumi M; Nakamichi Y; Kikuta T; Nishiwaki C
    Diabetes; 2006 Oct; 55(10):2819-25. PubMed ID: 17003348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
    Tanaka A; Azuma K; Toyofuku Y; Kurokawa A; Otsuka A; Mita T; Hirosea T; Fujitani Y; Miyauchi K; Daida H; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2006 Nov; 350(1):195-201. PubMed ID: 16997277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations.
    Aoyagi K; Ohara-Imaizumi M; Nishiwaki C; Nakamichi Y; Nagamatsu S
    Exp Diabetes Res; 2009; 2009():278762. PubMed ID: 20069052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
    Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
    Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
    Mine T; Miura K; Kajioka T; Kitahara Y
    Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulated expression of exocytotic proteins in pancreatic islets of diabetic GK rats.
    Zhang W; Khan A; Ostenson CG; Berggren PO; Efendic S; Meister B
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1038-44. PubMed ID: 11866470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIRF imaging of docking and fusion of single insulin granule motion in primary rat pancreatic beta-cells: different behaviour of granule motion between normal and Goto-Kakizaki diabetic rat beta-cells.
    Ohara-Imaizumi M; Nishiwaki C; Kikuta T; Nagai S; Nakamichi Y; Nagamatsu S
    Biochem J; 2004 Jul; 381(Pt 1):13-8. PubMed ID: 15128287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of glibenclamide and nateglinide upon pancreatic islet function in normal and diabetic rats.
    Laghmich A; Ladrière L; Malaisse-Lagae F; Malaisse WJ
    Pharmacol Res; 1999 Dec; 40(6):475-82. PubMed ID: 10660944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of syntaxin-1 and SNAP-25 clusters with docking and fusion of insulin granules analysed by total internal reflection fluorescence microscopy.
    Ohara-Imaizumi M; Nishiwaki C; Nakamichi Y; Kikuta T; Nagai S; Nagamatsu S
    Diabetologia; 2004 Dec; 47(12):2200-7. PubMed ID: 15647897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
    Ghanaat-Pour H; Sjöholm A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-SNAP functions in insulin exocytosis from mature, but not immature secretory granules in pancreatic beta cells.
    Nakamichi Y; Nagamatsu S
    Biochem Biophys Res Commun; 1999 Jun; 260(1):127-32. PubMed ID: 10381355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes.
    Kitahara Y; Miura K; Takesue K; Mine T; Wada R; Uchida Y; Ito S; Yagihashi S
    Metabolism; 2002 Nov; 51(11):1452-7. PubMed ID: 12404197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics, insulinotropic action and hypoglycemic effect of nateglinide and glibenclamide in normal and diabetic rats.
    Courtois P; Jijakli H; Ladriere L; Oguzhan B; Sener A; Malaisse WJ
    Int J Mol Med; 2003 Jan; 11(1):105-9. PubMed ID: 12469228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea induced beta-cell apoptosis in cultured human islets.
    Maedler K; Carr RD; Bosco D; Zuellig RA; Berney T; Donath MY
    J Clin Endocrinol Metab; 2005 Jan; 90(1):501-6. PubMed ID: 15483097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity.
    Ling Z; Wang Q; Stangé G; In't Veld P; Pipeleers D
    Diabetes; 2006 Jan; 55(1):78-85. PubMed ID: 16380479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nateglinide suppresses postprandial hypertriglyceridemia in Zucker fatty rats and Goto-Kakizaki rats: comparison with voglibose and glibenclamide.
    Mine T; Miura K; Kitahara Y; Okano A; Kawamori R
    Biol Pharm Bull; 2002 Nov; 25(11):1412-6. PubMed ID: 12419950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
    Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
    Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.